Trial Profile
Examining the Relationship Between Diabetic Macular Edema and Obstructive Sleep Apnea: Prevalence, Association and Impact
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2022
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- Acronyms DME-OSA
- 23 Nov 2020 Planned End Date changed from 1 Jan 2019 to 1 Dec 2020.
- 30 Jul 2018 New trial record